Systematic review and meta-analysis of adult multipotent stromal/stem cell treatment for equine tendinopathy and desmopathy.

Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for production animal practice, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in Frontiers in veterinary science in 2026 evaluated systematic review and meta-analysis of adult multipotent stromal/stem cell treatment for equine tendinopathy and desmopathy..

Key Findings

Over the last few decades, cell and cell-based therapies emerged as treatment options for equine tendinopathy and desmopathy. The objective of this study was to critically evaluate outcomes following treatment of equine tendinopathy or desmopathy with adult multipotent stromal/stem cells (MSCs). The PubMed and Web of Science databases were searched for "equine/horse," "tendon/tendinopathy/tendonitis/ligament/ligamentopathy/desmopathy/desmitis," "stem/stromal/mesenchymal/multipotent," and "cell" from January 2001 to June 2025. Studies were identified according to PRISMA guidelines, and independent reviewers extracted the following...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for production animal practice.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

Read the full article here.

More news

Articles Companion animals

21 May 2026

21 May 2026

Clinical benefit of faecal microbiota transplantation administered via a single retention enema as an adjunctive treatment in dogs with chronic enteropathy: a randomised controlled trial.

Clinical evidence update from The Journal of small animal practice

To evaluate the clinical benefit of faecal microbiota transplantation administered via a single retention enema, as an adjunctive treatment in the

Read more

Like0

Dislike0

The Veterinary33 debates Veterinary News

20 May 2026

20 May 2026

AASV Honors Dr. Robyn Fleck, V92 with the Technical Services/Allied Industry Veterinarian of the Year Award

Fleck was one of the first female swine veterinarians

Read more

Like0

Dislike0

Latest News Public health

20 May 2026

20 May 2026

Chewy Announces Participation in the J.P. Morgan 2026 Global Technology, Media and Communications Conference

Chewy, Inc. (NYSE: CHWY) (“Chewy”), a trusted destination for pet parents and partners everywhere, announced today that Sumit Singh, Chief Executive Officer, will participate in a fireside chat...

Read more

Like0

Dislike0

Latest News Companion animals

20 May 2026

20 May 2026

Unlicensed antiviral products used for the at-home treatment of feline infectious peritonitis contain GS-441524 at significantly different amounts than advertised

To analyze the content of unlicensed GS-441524-like products being used as a largely successful at-home treatment for cats suspected to have FIP. The remdesivir content and pH were also measured.

Read more

Like0

Dislike0

Articles Companion animals

20 May 2026

20 May 2026

Low-Invasive Biomarkers of Canine Mammary Tumours

Canine mammary tumours (CMTs) are the most common type of tumours in older bitches.

Read more

Like0

Dislike0